lung damage from radiation therapy for breast cancer

Release time ：Dec-22,2024

Radiation therapy for breast cancer has the potential to cause pulmonary damage, with the severity varying from mild to severe, which can impact patients' respiratory function and overall quality of life.

Initially, minor pulmonary damage might present as symptoms such as coughing, chest tightness, or shortness of breath, typically emerging a few weeks post-radiotherapy and gradually improving over time. Progressing to moderate damage, patients may experience ongoing respiratory difficulties that hinder their daily activities. In the most severe cases, lung damage can lead to critical respiratory failure, posing a life-threatening risk. It is important to recognize that the likelihood and severity of lung damage are influenced by several factors, including the radiation dosage, the area treated, the patient's age, and their general health status.

Hence, regular pulmonary function monitoring is crucial for patients receiving radiation therapy for breast cancer. Should any respiratory symptoms arise, immediate medical consultation is advised, and treatment adjustments should be made under a physician's supervision. Additionally, patients are encouraged to maintain healthy lifestyle practices, such as smoking cessation and avoiding air pollution, to mitigate the risk of pulmonary damage.